The private equity firm Blue Cap AG
has announced the strategic sale of their 100% stake in the German medical technology specialist Wisap Medical Technology GmbH to a subsidiary of the Chinese Aohua Photoelectric Neikuijing Limited. Through the acquisition, Wisap Medical Technology GmbH, which specializes in the fields of laparoscopic and hysteroscopic gynecology, will gain access to distributors and customers for its core market of China. Completion of the transaction is scheduled for the third quarter of 2018 as soon as the antitrust clearance for the cross-border transaction is granted.
Aohua is one of the market leaders for flexible endoscopes in China and operates in over 80 countries worldwide. Through the acquisition of WISAP it will continue to expand its market presence in Europe. “With Aohua, we have found a strategic and well-connected partner that confirms WISAP’s business model and supports its growth strategy. In addition, our new shareholder gives us the opportunity to develop new technologies for endoscopic medicine and to open up new markets”, explains Stephan Hilgers, Managing Director of WISAP.
The headquarters of WISAP will remain in Hofolding. Both parties agreed to not disclose the purchase price.
MelchersRaffel acted as exclusive advisor to the seller Blue Cap AG in this transaction.